FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 113 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 469.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $991,000 | -92.3% | 26,300 | -96.5% | 0.00% | -100.0% |
| Q4 2020 | $12,857,000 | +6493.3% | 755,864 | +1728.4% | 0.00% | – |
| Q3 2020 | $195,000 | -78.6% | 41,340 | -72.3% | 0.00% | – |
| Q2 2020 | $910,000 | +186.2% | 149,053 | +6.3% | 0.00% | – |
| Q1 2020 | $318,000 | -54.4% | 140,236 | -7.7% | 0.00% | – |
| Q4 2019 | $698,000 | -18.0% | 152,014 | -30.8% | 0.00% | – |
| Q3 2019 | $851,000 | -10.4% | 219,770 | +39.6% | 0.00% | – |
| Q2 2019 | $950,000 | -16.9% | 157,475 | +84.6% | 0.00% | – |
| Q1 2019 | $1,143,000 | -25.8% | 85,292 | -48.5% | 0.00% | -100.0% |
| Q4 2018 | $1,540,000 | -60.3% | 165,596 | -40.5% | 0.00% | -50.0% |
| Q3 2018 | $3,877,000 | +66.8% | 278,535 | +89.4% | 0.00% | +100.0% |
| Q2 2018 | $2,325,000 | +48.3% | 147,047 | +61.1% | 0.00% | 0.0% |
| Q1 2018 | $1,568,000 | -25.3% | 91,264 | -4.7% | 0.00% | 0.0% |
| Q4 2017 | $2,100,000 | +39.9% | 95,784 | +161.0% | 0.00% | 0.0% |
| Q3 2017 | $1,501,000 | -10.1% | 36,700 | -33.8% | 0.00% | -50.0% |
| Q2 2017 | $1,669,000 | -78.1% | 55,400 | -73.7% | 0.00% | -71.4% |
| Q1 2017 | $7,629,000 | +2768.0% | 211,032 | +3881.7% | 0.01% | – |
| Q4 2016 | $266,000 | -27.7% | 5,300 | -41.5% | 0.00% | – |
| Q1 2016 | $368,000 | -96.7% | 9,065 | -96.6% | 0.00% | -100.0% |
| Q4 2015 | $11,037,000 | +243.6% | 265,967 | +27.4% | 0.01% | +300.0% |
| Q3 2015 | $3,212,000 | +580.5% | 208,745 | +1094.8% | 0.00% | – |
| Q4 2014 | $472,000 | +234.8% | 17,471 | +45.3% | 0.00% | – |
| Q3 2014 | $141,000 | – | 12,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|